Creative Planning’s NeuBase Therapeutics, Inc. Common Stock NBSE Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Shares Change % | Capital Flow | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2019
Q2 | – | Sell |
-2,308
| Closed | -$104K | – | 1974 |
|
|
2019
Q1 | $104K | Buy |
2,308
+2,138
| +1,258% | +$96.3K | ﹤0.01% | 1690 |
|
|
2018
Q4 | $6K | Sell |
170
-8
| -4% | -$282 | ﹤0.01% | 1792 |
|
|
2018
Q3 | $13K | Buy |
178
+13
| +8% | +$949 | ﹤0.01% | 1909 |
|
|
2018
Q2 | $13K | Hold |
165
| – | – | ﹤0.01% | 1888 |
|
|
2018
Q1 | $15K | Buy |
165
+10
| +6% | +$909 | ﹤0.01% | 1868 |
|
|
2017
Q4 | $115K | Buy |
155
+2
| +1% | +$1.48K | ﹤0.01% | 1697 |
|
|
2017
Q3 | $44K | Buy |
153
+8
| +6% | +$2.3K | ﹤0.01% | 1773 |
|
|
2017
Q2 | $37K | Buy |
145
+116
| +400% | +$29.6K | ﹤0.01% | 2741 |
|
|
2017
Q1 | $10K | Hold |
29
| – | – | ﹤0.01% | 3568 |
|
|
2016
Q4 | $17K | Hold |
29
| – | – | ﹤0.01% | 3150 |
|
|
2016
Q3 | $33K | Hold |
29
| – | – | ﹤0.01% | 2655 |
|
|
2016
Q2 | $32K | Buy |
29
+14
| +93% | +$15.4K | ﹤0.01% | 2429 |
|
|
2016
Q1 | $20K | Sell |
15
-13
| -46% | -$17.3K | ﹤0.01% | 2748 |
|
|
2015
Q4 | $68K | Buy |
28
+13
| +87% | +$31.6K | ﹤0.01% | 1857 |
|
|
2015
Q3 | $17K | Buy |
+15
| New | +$17K | ﹤0.01% | 2846 |
|
|
2015
Q2 | – | Hold |
0
| – | – | – | 3027 |
|
|
2015
Q1 | – | Hold |
0
| – | -$1K | – | 4270 |
|
|
2014
Q4 | – | Hold |
0
| – | – | – | 3896 |
|
|
2014
Q3 | – | Sell |
-4
| Closed | -$14K | – | 4024 |
|
|
2014
Q2 | $14K | Buy |
+4
| New | +$14K | ﹤0.01% | 2666 |
|